Evidence map›Paper›PMID 22383952›Full record

ArticlePloS one2012

Transcriptional regulation of N-acetylglutamate synthase.

Sandra Kirsch Heibel, Giselle Yvette Lopez, Maria Panglao, Sonal Sodha, Leonardo Mariño-Ramírez, Mendel Tuchman, Ljubica Caldovic

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. International journal of molecular sciences · 2023
    Article
  5. Review
  6. Article
  7. Genetic Polymorphisms inInternational journal of molecular sciences · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Glucagon Receptor Signaling and Glucagon Resistance.International journal of molecular sciences · 2019
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Sandra Kirsch HeibelCenter for Genetic Medicine Research, Children's National Medical Center, Washington, DC, United States of America.
Giselle Yvette Lopez
Maria Panglao
Sonal Sodha
Leonardo Mariño-Ramírez
Mendel Tuchman
Ljubica Caldovic
Children's National · USDuke Medical Center · USGeorge Washington University · USJohns Hopkins University · USNational Center for Biotechnology Information · USUniversity of Maryland, College Park · US

Funding

N-acetylglutamate Synthase: Structure, Function & DefectsR01DK064913 · NIDDK · CHILDREN'S RESEARCH INSTITUTE · PI CALDOVIC, LJUBICA MORIZONO · 2003 to 2017
$4.9M
Genome Assemblies, Analyses, and ComparisonsZIALM082713 · NLM · NATIONAL LIBRARY OF MEDICINE · PI LANDSMAN, DAVID · 2013 to 2025
$3.5M
Intramural NIH HHS Z99 LM999999NIDDK NIH HHS R01 DK064913NIDDK NIH HHS R01DK064913
6 · The paper itself

Abstract

The urea cycle converts toxic ammonia to urea within the liver of mammals. At least 6 enzymes are required for ureagenesis, which correlates with dietary protein intake. The transcription of urea cycle genes is, at least in part, regulated by glucocorticoid and glucagon hormone signaling pathways. N-acetylglutamate synthase (NAGS) produces a unique cofactor, N-acetylglutamate (NAG), that is essential for the catalytic function of the first and rate-limiting enzyme of ureagenesis, carbamyl phosphate synthetase 1 (CPS1). However, despite the important role of NAGS in ammonia removal, little is known about the mechanisms of its regulation. We identified two regions of high conservation upstream of the translation start of the NAGS gene. Reporter assays confirmed that these regions represent promoter and enhancer and that the enhancer is tissue specific. Within the promoter, we identified multiple transcription start sites that differed between liver and small intestine. Several transcription factor binding motifs were conserved within the promoter and enhancer regions while a TATA-box motif was absent. DNA-protein pull-down assays and chromatin immunoprecipitation confirmed binding of Sp1 and CREB, but not C/EBP in the promoter and HNF-1 and NF-Y, but not SMAD3 or AP-2 in the enhancer. The functional importance of these motifs was demonstrated by decreased transcription of reporter constructs following mutagenesis of each motif. The presented data strongly suggest that Sp1, CREB, HNF-1, and NF-Y, that are known to be responsive to hormones and diet, regulate NAGS transcription. This provides molecular mechanism of regulation of ureagenesis in response to hormonal and dietary changes.

Indexed as

Gene Expression Regulation, EnzymologicTranscription, GeneticAmino-Acid N-AcetyltransferaseAnimalsBase SequenceCarbamoyl-Phosphate Synthase (Ammonia)CCAAT-Binding FactorCCAAT-Enhancer-Binding ProteinsCyclic AMP Response Element-Binding ProteinEnhancer Elements, GeneticHepatocyte Nuclear Factor 1-alphaHumansMiceMice, Inbred C57BLMolecular Sequence DataPromoter Regions, GeneticAmino-Acid N-AcetyltransferaseCarbamoyl-Phosphate Synthase (Ammonia)CCAAT-Binding FactorCCAAT-Enhancer-Binding ProteinsCREB1 protein, humanCyclic AMP Response Element-Binding ProteinHepatocyte Nuclear Factor 1-alphaHNF1A protein, humanSmad3 ProteinSMAD3 protein, humanSp1 Transcription FactorTranscription Factor AP-2

Identifiers

PMID22383952
PMCPMC3287996
OpenAlexW2087682411

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.